Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erysipelatous inflammation: a new view on a long-standing problem].

S A Shliapnikov, N R Naser, S R Eremin

    Vestnik Khirurgii Imeni I. I. Grekova
    |January 1, 2005
    PubMed
    Summary

    Terbinafine hydrochloride effectively prevents recurrent erysipelatous inflammation. This antimitotic treatment significantly reduced recurrence rates in patients compared to a control group.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Susceptibility of gramnegative carbapenemase-producing bacteria to various group antibiotics].

    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2014
    Same author

    [Cholangitis and biliary sepsis: problem and ways of solution].

    Vestnik khirurgii imeni I. I. Grekova·2009
    Same author

    [Surgical infection of soft tissue--a problem of adequate antibiotic therapy].

    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2003
    Same author

    [Comparative clinical-economic analysis of antibiotic therapy in pyogenic inflammatory diseases of the lower extremities].

    Vestnik khirurgii imeni I. I. Grekova·2003
    Same author

    [Secondary and tertiary peritonitis: the role of antibacterial therapy in the complex treatment].

    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2002
    Same author

    [Surgical sepsis (discussion aspects, problems)].

    Khirurgiia·2000

    Area of Science:

    • Dermatology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Erysipelatous inflammation, commonly known as erysipelas, is a bacterial skin infection often characterized by recurrent episodes.
    • Managing and preventing recurrent erysipelas poses a clinical challenge, impacting patient quality of life.

    Purpose of the Study:

    • To evaluate the prophylactic efficacy of terbinafine hydrochloride (Lamisil) in preventing recurrent erysipelatous inflammation.

    Main Methods:

    • A study involving 72 patients with primary and recurring erysipelatous inflammation.
    • Patients received antimitotic treatment with terbinafine hydrochloride.
    • Recurrence rates were compared between the treatment group and a control group.

    Main Results:

    • Terbinafine hydrochloride demonstrated highly reliable effectiveness (p<0.001) in preventing recurrences.
    • The recurrence frequency in the terbinafine hydrochloride treatment group was 7.1%.
    • In contrast, the control group experienced a recurrence frequency of 45.5%.

    Conclusions:

    • Antimitotic treatment with terbinafine hydrochloride is a reliable prophylactic strategy for erysipelatous inflammation.
    • This treatment significantly reduces the incidence of recurrent erysipelas.

    Related Experiment Videos